Physician profile
Rona Law
NPI 1164953170
$22,115.47
in general payments reported to CMS, 2019-2025
37 companies · $2,061 in 2025
The $2,061 reported for 2025 was more than what 84% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,854 · 2021: $2,049 · 2022: $9,284 · 2023: $3,368 · 2024: $3,500 · 2025: $2,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,030 · Food and Beverage: $2,899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,030.21 |
| Food and Beverage | $2,898.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vilex LLC | $4,622.44 | 2023-2024 | |
| Pylant Medical | $3,675.84 | 2022 | |
| Arthrex, INC. | $2,048.82 | 2021 | |
| Stryker Corporation | $1,775.30 | 2023-2025 | Ortholoc 3di, Hoffmann, Salvation |
| Medline Industries LP | $1,470.64 | 2022-2025 | |
| Mid-Atlantic Surgical Systems, LLC | $1,461.94 | 2020 | |
| Paragon 28, INC. | $1,351.22 | 2020-2023 | Apex 3d |
| Treace Medical Concepts, INC. | $1,323.96 | 2022-2024 | |
| Trimed, INC. | $812.23 | 2022 | |
| Smith+Nephew, INC. | $683.49 | 2020-2025 | Evos, Grafix Pl, Cadence |
| Orthofix Medical, INC. | $654.01 | 2022-2025 | Physio-Stim |
| International Life Sciences | $577.80 | 2023 | |
| Medical Device Business Services, INC. | $334.38 | 2022 | |
| Extremity Medical | $182.00 | 2023 | Io Fix |
| Celularity INC. | $137.15 | 2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $132.94 | 2022 | |
| Ossio INC | $130.26 | 2023 | |
| Kerecis Limited | $78.21 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Cardiovascular Systems INC. | $77.62 | 2022 | |
| Mimedx Group, INC. | $71.55 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $64.11 | 2022 | |
| Medtronic, INC. | $54.59 | 2023 | Intellis Adaptivestim |
| Wright Medical Technology, INC. | $53.01 | 2020 | |
| Integra Lifesciences Corporation | $45.24 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Amgen INC. | $35.80 | 2024 | Krystexxa |
| Polynovo North America LLC | $35.79 | 2025 | Novosorb Btm |
| Theragen, INC. | $28.00 | 2025 | Actastim-S |
| Fidia Pharma USA INC. | $27.90 | 2025 | Hymovis, Triluron |
| Cumberland Pharmaceuticals, INC. | $23.14 | 2024 | Caldolor |
| Nevro Corp. | $22.96 | 2023 | Senza |
| Next Science LLC | $22.94 | 2023 | Xperience, Blastx, Surgx |
| Hydrocision, INC. | $21.18 | 2022 | |
| Abbott Laboratories | $20.93 | 2025 | Eterna |
| Globus Medical, INC. | $18.95 | 2025 | Omnia |
| Spr Therapeutics, INC | $18.94 | 2025 | Sprint Pns System |
| Axogen | $13.90 | 2023 | Avance Nerve Graft |
| Musculoskeletal Transplant Foundation INC. | $6.29 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rona Law listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.